Cleared Traditional

K113732 - IPLAN (IPLAN CRANIAL, IPLAN STEREOTAXY, IPLAN ENT, IPLAN CMF, IPLAN VIEW, IPLAN SPINE)

K113732 is an FDA 510(k) clearance for IPLAN (IPLAN CRANIAL, manufactured by Brainlab AG. The device is a Class 2 Radiology device with product code JAK cleared through the Traditional 510(k) pathway after a 140-day FDA review.

K113732 · Brainlab AG · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2012
Decision
140d
Days
Class 2
Risk

K113732 is an FDA 510(k) clearance for the IPLAN (IPLAN CRANIAL, IPLAN STEREOTAXY, IPLAN ENT, IPLAN CMF, IPLAN VIEW, IPL.... Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Brainlab AG (Feldkirchen, DE). The FDA issued a Cleared decision on May 7, 2012 after a review of 140 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Brainlab AG devices

FDA 510(k) Submission Details - K113732

510(k) Number K113732 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 19, 2011
Decision Date May 07, 2012
Days to Decision 140 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d slower than avg
Panel avg: 107d · This submission: 140d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAK Device Classification - Class 2, Special Controls

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 717
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K113732.
SOMATOM PERSPECTIVE
K113287 · Siemens Medical Solutions USA, Inc. · May 2012
SOMATOM DEFINITION EDGE
K120579 · Siemens Medical Systems, Inc. · May 2012
SOMATOM DEFINITION FLASH
K121072 · Siemens Medical Systems, Inc. · May 2012
GUIDESHOT OPTION, SCENARIA WHOLE-BODY X-RAY CT SYSTEM
K113341 · Hitachi Medical Systems America, Inc. · May 2012
CT-GUIDE NEEDLE GUIDANCE SYSTEM
K120300 · Activiews, Ltd. · Apr 2012
SYNGO CT DYNAMIC ANGIO
K120331 · Siemens AG Medical Solutions · Apr 2012